What is the recommended vaccination approach for a 33-year-old adult who lacks immunity to measles and mumps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MMR Vaccination for a 33-Year-Old Without Immunity

A 33-year-old adult lacking immunity to measles and mumps should receive two doses of MMR vaccine separated by at least 28 days. 1

Vaccination Schedule

Adults at high risk for exposure require two doses of MMR vaccine, while other adults aged ≥18 years need at least one dose. 1 Given this patient's complete lack of immunity to both measles and mumps, the two-dose series is the appropriate approach:

  • First dose: Administer immediately 1
  • Second dose: Administer at least 28 days (4 weeks) after the first dose 2, 1

This two-dose recommendation applies particularly to adults at increased risk, including healthcare workers, students in post-secondary educational institutions, and international travelers. 1, 3

Rationale for Two Doses

The two-dose strategy is critical because:

  • Single-dose vaccination may not provide adequate protection, particularly for mumps, where waning immunity is more pronounced than for measles or rubella 4
  • Recent outbreak data demonstrates that even two-dose vaccinees can develop measles, though they experience milder symptoms and fewer complications 5
  • At 10 years post-vaccination, approximately 73% of two-dose recipients maintain protective mumps antibody levels, compared to 94% for measles and 84% for rubella 4

Documentation and Verification

Pre-vaccination serologic screening is not required for this patient. 6 The CDC guidelines explicitly state that routine serologic screening before vaccination is unnecessary unless a facility deems it cost-effective, and testing is appropriate only when susceptible individuals will be vaccinated promptly afterward. 6

After vaccination, routine titer checking is also not recommended for individuals who receive documented two-dose MMR vaccination. 6 The exception would be if this patient receives immune globulin within 14 days of vaccination, in which case serologic testing should be performed at least 3 months later to confirm antibody production. 6

Special Considerations

If Healthcare Worker

All healthcare workers must have documented evidence of measles and rubella immunity regardless of patient-care responsibilities. 6 For workers born in 1957 or later (which includes this 33-year-old), adequate protection requires two doses of measles-containing vaccine and at least one dose of rubella-containing vaccine. 6

Outbreak Settings

During active measles or mumps outbreaks, rapid vaccination takes precedence over any serologic testing. 6 The primary focus should be immediate vaccination of susceptible individuals rather than confirming immunity through titers. 6

Post-Vaccination Expectations

More than 90% of two-dose MMR recipients maintain protective measles antibody levels at 10 years, though mumps protection is notably lower at approximately 70-73%. 4 This patient should understand that while protection is excellent, mumps immunity may wane more significantly over time compared to measles and rubella. 4

Common Pitfalls to Avoid

  • Do not delay vaccination to obtain pre-vaccination titers unless there is documented evidence of prior vaccination or disease 6
  • Do not administer immune globulin products within 14 days of MMR vaccination as this can interfere with vaccine response and necessitate repeat serologic testing 6
  • Do not assume birth before 1957 confers immunity in this case, as the patient is only 33 years old and falls into the category requiring documented vaccination 6, 1

References

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Research

Measles, mumps, and rubella vaccines.

Infectious disease clinics of North America, 1990

Research

Measles Outbreak Associated with an Infectious Traveler - Colorado, May-June 2025.

MMWR. Morbidity and mortality weekly report, 2026

Guideline

Guidelines for MMR IgG Titer Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.